Publicaciones en colaboración con investigadores/as de University of California, San Diego (23)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

2022

  1. Clinical, histological and molecular profiling of different stages of alcohol-related liver disease

    Gut, Vol. 71, Núm. 9, pp. 1856-1866

  2. The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

    The Lancet, Vol. 399, Núm. 10319, pp. 61-116

2021

  1. Author Correction: A community-based transcriptomics classification and nomenclature of neocortical cell types (Nature Neuroscience, (2020), 23, 12, (1456-1468), 10.1038/s41593-020-0685-8)

    Nature Neuroscience

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Serum acylcarnitines associated with high short-term mortality in patients with alcoholic hepatitis

    Biomolecules, Vol. 11, Núm. 2, pp. 1-14

2020

  1. A Novel Mouse Model of Acute-on-Chronic Cholestatic Alcoholic Liver Disease: A Systems Biology Comparison With Human Alcoholic Hepatitis

    Alcoholism: Clinical and Experimental Research, Vol. 44, Núm. 1, pp. 87-101

  2. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    Journal for ImmunoTherapy of Cancer, Vol. 8, Núm. 1

  3. Hepatic gap junctions amplify alcohol liver injury by propagating cGAS-mediated IRF3 activation

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 117, Núm. 21

  4. Imaging-AMARETTO: An imaging genomics software tool to interrogate multiomics networks for relevance to radiography and histopathology imaging biomarkers of clinical outcomes

    JCO Clinical Cancer Informatics, Vol. 4, pp. 421-435

  5. Recent advances in alcohol-related liver disease (ALD): Summary of a Gut round table meeting

    Gut, Vol. 69, Núm. 4, pp. 764-780

2019

  1. Creation and analysis of biochemical constraint-based models using the COBRA Toolbox v.3.0

    Nature Protocols, Vol. 14, Núm. 3, pp. 639-702

  2. Identification of resistance pathways specific to malignancy using organoid models of pancreatic cancer

    Clinical Cancer Research, Vol. 25, Núm. 22, pp. 6742-6755

2018

  1. Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis

    Journal of Hepatology, Vol. 69, Núm. 2, pp. 396-405

  2. Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies

    PLoS Medicine, Vol. 15, Núm. 1

2017

  1. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 88, Núm. 2, pp. 152-164

  2. Recommendations for radioembolisation after liver surgery using yttrium-90 resin microspheres based on a survey of an international expert panel

    European Radiology, Vol. 27, Núm. 12, pp. 4923-4930

2013

  1. Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Núm. 30, pp. 12391-12396

2012

  1. ERK1/2 regulation of CD44 modulates oral cancer aggressiveness

    Cancer Research, Vol. 72, Núm. 1, pp. 365-374